Aquablation for early prostate cancer under active surveillance
Part of Cancer, Kidney & urinary clinical trials.
This study tests a minimally invasive robotic water-jet procedure (called Aquablation) for men with early-stage prostate cancer who are being monitored closely rather than treated immediately. The goal is to see if this approach can help men avoid or delay traditional surgery or radiation while managing their cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a biological male, at least 45 years old
- You were diagnosed with early-stage prostate cancer (Grade Group 1 or 2) within the last 18 months
- Your cancer is confined to the prostate (Stage T2c or lower) with PSA level below 15
- Your prostate is large enough (at least 25 ml) for the procedure
- You have never received any treatment for prostate cancer (surgery, radiation, hormone therapy, etc.)
- You are in good enough health to undergo anesthesia and a robotic water-jet procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well Aquablation works for men with an enlarged prostate (BPH) in Canada. You may be eligible if your clinician believes Aquablation is an appropriate treatment and you can complete the study visits and questionnaires.
This trial studies a “watchful waiting” approach, where doctors closely monitor certain prostate cancers with regular checkups and repeat biopsies. It may help people avoid or delay treatment side effects while watching for signs the cancer needs treatment.
This is a registry study that follows men with low-risk prostate cancer who choose active surveillance instead of immediate treatment. It helps doctors understand how safe and effective active surveillance is, including confirming results with repeat biopsies.
This trial tests whether an exercise program can help men with early-stage prostate cancer who are being monitored instead of treated. If you are not very active now, you may be able to join a structured exercise plan to see if it improves your health and cancer signs.
This registry study is for men with an enlarged prostate (BPH) who have had or will have a procedure called Aquablation. It will collect information to learn more about the treatment.
This trial tests a newer way to treat certain low- to intermediate-risk prostate cancers using MRI guidance and an ultrasound probe placed through the urethra. It aims to destroy the tumor while using imaging to help target it more precisely.
Hear when a new Localized Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.